The ideal vector system would have the following characteristics:

(1) an adequate carrying capacity; (2) to be undetectable by the immune system; (3) to be non-inflammatory; (4) to be safe to the patients with pre-existing lung inflammation; (5) to have an efficiency sufficient to correct the cystic fibrosis phenotype; (6) to have long duration of expression and/or the ability to be safely re-administered.